Funding and Training

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Researchers in the lab.

CGH helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.

Explore a full listing of NIH funding announcements

 

Funding Opportunities

Turkey-US Collaborative Program for Affordable Medical Technologies 

The National Cancer Institute, through its Center for Global Health, Division of Cancer Control and Population Sciences, Division of Cancer Treatment and Diagnosis, and National Institute of Biomedical Imaging and Bioengineering, invites applications from research partnerships formed between scientists from U.S. and Turkey to accelerate the development of appropriate affordable diagnostic and therapeutic technologies, which address medical needs in low-middle resource settings. The collaborations should be aimed at developing medical technologies that can significantly impact underserved populations within the United States and/or Turkey, and potentially populations in Low and Middle Income Countries, particularly in Africa, the Middle East,  Eastern Europe, and Latin America. 

Key Dates:
Open Date: September 5, 2015
Application Due Date: October 8, 2015, by 5:00 PM local time of applicant organization

 

Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp)

The National Cancer Institute (NCI), through its Center for Global Health (CGH), seeks to promote cancer prevention and control (CPC) research in low- and middle-income countries (LMICs) through collaborations and research partnerships between the NCI-designated cancer centers and partner institutions in LMICs. Through this funding opportunity announcement (FOA), the NCI will provide administrative supplement awards to currently-funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control. These supplements are designed to stimulate and strengthen CPC twinning programs between researchers at the NCI-designated cancer centers and institutions in LMICs. It is anticipated that outcomes of this supplement will include collaborative research grants between investigators at the NCI-designated cancer centers and LMIC institutions.

Key Dates:
Open Date: May 8, 2015
Application Due Date: Closed

 

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

The National Cancer Institute, Division of Cancer Treatment and Diagnosis has developed a funding opportunity to encourage applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for pre-clinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem. 

Key Dates:
Application Due Date:
Closed

 

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)

The National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering have developed a funding opportunity to support the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays that are clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs.

Key Dates:
Application Due Date:
Closed

For more information on this initiative, please read Technologies for Global Health RFA FAQs or join CGH for one of the following Info Session webinars.  

Info Session Webinar Slides
Cancer Detection, Diagnostic and Treatment Technologies for Global Health Webinar – Overview and Goals
Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3)

 

Funding Opportunity Announcement for Cancer Research in the Caribbean

CGH and the Caribbean Public Health Agency (CARPHA) have developed a co-funded opportunity to support the research of cancers that are of a significant burden within a Caribbean population or community, a Caribbean country, or throughout the Caribbean.

Key Dates:
Application Due Date: Closed
Scientific Review:
January 31, 2015

 

Training Opportunities

  • CGH Short Term Scientist Exchange Program (STSEP)

    The STSEP promotes collaborative research between established U.S. and foreign scientists from low- and middle-income countries (LMICs) and upper-middle income countries by supporting, in part, exchange visits of cancer researchers between U.S. and foreign laboratories that are six months or less.

  • NCI Summer Curriculum in Cancer Prevention Program

    This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs, the International Atomic Energy Agency’s Programme of Action for Cancer Therapy (IAEA-PACT), and the All-Ireland Cancer Consortium (AICC).

  • Posted: June 23, 2014